🩻 Medically reviewed

Mammogram Limitations and Accuracy: How Reliable Is Breast Screening?

How accurate are mammograms? False positives, false negatives, dense breasts and overdiagnosis explained. Reviewed against NHS and WHO guidelines.

Reviewed against NHS & WHO guidelines Last reviewed: May 2026 For educational purposes — not medical advice

Key facts

The NHS invites women and people with breasts for their first mammogram between ages 50 and 53, then every 3 years until 71 (programme covers 50 to 70; some areas trial 47 to 73).
According to Cancer Research UK, around 4 out of every 100 people screened are recalled for further tests, and most people who are recalled are found not to have cancer.
UK research shows mammogram sensitivity falls from roughly three quarters in the least dense breasts to about half in the densest breasts.
An independent UK review estimated screening prevents around 1,300 breast cancer deaths a year in the UK; NHS England now estimates around 1,400 lives saved a year in England.

Why accuracy matters when you think about screening

A mammogram is an X-ray of the breast. In the UK, the NHS Breast Screening Programme uses mammograms to look for breast cancers that are too small to see or feel. Finding cancer early often means simpler treatment and a better chance of recovery, so screening saves many lives each year.

But mammograms, like every medical test, are not perfect. Sometimes they raise concern when nothing is wrong. Sometimes they miss a cancer that is there. And sometimes they find a cancer that would never have caused harm. Understanding these limits is not a reason to avoid screening. It simply helps you go in with realistic expectations and make a choice that is right for you. The NHS is clear that whether you attend screening is your decision.

This guide is educational information, not personal medical advice. If you have a symptom you are worried about, or questions about your own risk, please speak to your GP or breast care team. Screening is for people without symptoms; if you notice a change in your breast, contact your GP straight away rather than waiting for your next invitation.

Who is invited, and how mammograms work

According to the NHS, women and people with breasts are invited for their first breast screening between the ages of 50 and 53, then every 3 years until they turn 71. The core programme covers ages 50 to 70. Some areas have been taking part in a trial offering screening to a wider age range, from 47 to 73. People over 71 can still ask for screening by contacting their local unit.

During the test, a radiographer places each breast on a flat plate, and a second plate presses down to flatten it for a few seconds. The NHS takes two X-rays of each breast, from above and from the side. The pressure can feel uncomfortable but only lasts a moment. A specialist doctor then reads the images, looking for anything unusual.

Mammograms use a low dose of radiation. The NHS notes this very slightly increases the chance of cancer over a lifetime, but uses low doses to keep the risk as small as possible, and research shows the benefits of screening outweigh this small risk.

False positives: when you are called back but do not have cancer

A false positive is when a mammogram looks abnormal and you are recalled for more tests, but those tests show you do not have cancer. According to Cancer Research UK, around 4 out of every 100 people screened are called back for further tests. The majority of people who are recalled are found not to have cancer.

So a recall is common and most often turns out to be nothing serious. Being called back does not mean you have cancer. It usually means the doctor wants a closer look, perhaps with more mammogram views, an ultrasound, or a small sample (biopsy).

The hardest part of a false positive is the worry it causes. Cancer Research UK notes that being recalled and then cleared can be a frightening and anxious experience, even though it ends in good news. Knowing this in advance can make a recall letter a little less alarming.

  • A recall is a request for more information, not a diagnosis.
  • Most people recalled after screening do not have cancer.
  • Further tests may include extra mammogram images, an ultrasound scan, or a biopsy.
  • It is normal to feel anxious while you wait. Support from your breast care team and charities is available.

False negatives and interval cancers: when a cancer is missed

A false negative is when a mammogram looks normal but a cancer is actually present. The NHS explains that screening does not find every cancer. Some cancers are very small, or sit in an area that is hard to see on the X-ray, and can be missed.

A related idea is the interval cancer: a breast cancer that appears in the gap between one screening appointment and the next. Because the NHS screens every 3 years, a cancer can sometimes start and grow during that interval, after a clear mammogram. This is one reason it is so important to stay breast aware between appointments.

This is also why a normal mammogram result is reassuring but not a guarantee. If you notice a new lump, a change in the size or shape of your breast, skin or nipple changes, or any unusual discomfort, do not wait for your next invitation. Contact your GP, even if your last mammogram was clear.

Dense breasts: why they make mammograms harder to read

Breasts are made of fatty tissue and denser glandular and connective tissue. On a mammogram, fatty tissue looks dark, while dense tissue looks white, and so do many cancers. When there is a lot of dense tissue, it can hide a cancer the way white chalk is hard to spot on a white wall. Dense breasts are common and are simply a normal variation, although they are more usual in younger people.

UK research shows that mammograms are less sensitive in dense breasts. In studies, the proportion of cancers picked up fell from around three quarters in the least dense breasts to roughly half in the densest breasts. Interval cancers, those appearing between screens, are also more common in people with very dense breasts. This is partly why mammograms are not routinely offered to people under 50, whose breasts tend to be denser.

You cannot usually tell from the outside whether you have dense breasts; it is seen on the mammogram. The UK does not currently offer routine extra tests based on density alone. If you have a strong family history or other risk factors, your GP can refer you to a specialist who may discuss additional imaging, such as a breast MRI, where appropriate. You can read more in our guides on dense breasts and on breast MRI screening.

Overdiagnosis: finding cancers that may never cause harm

Overdiagnosis is one of the less obvious limits of screening. It means finding a cancer that is real, but so slow-growing it would never have caused symptoms or harm during a person's lifetime. Because doctors cannot yet reliably tell which cancers are harmless, these cancers are usually treated, which can mean surgery, radiotherapy or other treatments that a person did not truly need.

An independent UK review, jointly commissioned by Cancer Research UK and the Department of Health, looked carefully at the balance of benefits and harms. According to Cancer Research UK, the review estimated that screening prevents around 1,300 deaths from breast cancer each year in the UK, while leading to around 4,000 people being overdiagnosed each year. Put another way, the review estimated that for every life saved, roughly 3 people are overdiagnosed and may receive treatment they did not need.

More recent figures from NHS England suggest the programme now saves around 1,400 lives a year in England. Research continues into how to reduce overdiagnosis, for example by better predicting which cancers are slow-growing. The key message from the NHS is that screening overall does more good than harm, but it is honest about this trade-off so you can weigh it for yourself.

Weighing it up: making an informed screening choice

There is no single right answer that fits everyone. The NHS provides a leaflet, sometimes called Helping you decide, with the screening invitation precisely so people can think it through. Screening is a personal choice, and you are free to attend, to decline, or to take time to decide.

  • The main benefit: screening is the best way to find breast cancer early, when treatment is often simpler and more likely to succeed.
  • False positives: a recall is fairly common and usually turns out not to be cancer, but the wait can be stressful.
  • False negatives and interval cancers: a clear result is reassuring but not a guarantee, so stay breast aware between screens.
  • Dense breasts: mammograms are less accurate when breasts are dense, which is worth discussing with your GP if you also have other risk factors.
  • Overdiagnosis: some cancers found by screening would never have caused harm, but cannot yet be told apart from dangerous ones.

If you are unsure, your GP or your local breast screening unit can talk you through what screening means for your individual situation. Asking questions is always welcome.

Early detection and fair access for everyone

Mammograms have limits, but used well, they remain one of the most powerful tools for catching breast cancer early. Their value depends not only on the technology, but on people being able to reach screening in the first place. In many underserved communities, distance, cost, awareness and other barriers mean far fewer people are screened, and cancers are often found later, when they are harder to treat.

This is at the heart of our charity's mission: supporting early detection and improving access to screening and diagnosis in underserved communities. Better access, alongside honest information about what mammograms can and cannot do, helps more people benefit from early detection while making choices that are right for them.

Whatever you decide about your own screening, staying breast aware and acting promptly on any changes remains one of the most important things you can do. If something does not feel right, contact your GP.

Frequently asked questions

If my mammogram is normal, can I be sure I do not have breast cancer?
A normal result is reassuring, but the NHS explains that mammograms do not find every cancer. Some are too small to see or are hidden by dense tissue, and cancers can also appear in the gap between screenings. Stay breast aware, and contact your GP if you notice any new change, even soon after a clear result.
Does being called back after screening mean I have cancer?
No. A recall means the doctor wants a closer look, often with extra images, an ultrasound or a biopsy. According to Cancer Research UK, around 4 in every 100 people screened are recalled, and the majority of them are found not to have cancer. It is normal to feel anxious while you wait for results.
What are dense breasts and do they affect my mammogram?
Dense breasts have more glandular and connective tissue, which looks white on a mammogram, the same as many cancers, so cancers can be harder to spot. UK research shows mammograms are less accurate in dense breasts. Density is usually only seen on the mammogram itself. If you have other risk factors, your GP can discuss whether extra tests are appropriate.
What is overdiagnosis and should it stop me being screened?
Overdiagnosis means finding a cancer that would never have caused harm in your lifetime, but is still treated because doctors cannot yet tell harmless cancers apart. A UK review estimated around 4,000 people are overdiagnosed each year, against around 1,300 lives saved. The NHS concludes screening does more good than harm overall, but shares these figures so you can decide for yourself.
Is it my choice whether to have breast screening?
Yes. The NHS is clear that breast screening is your decision. You can attend, decline, or take time to think it over, and you can discuss the benefits and limits with your GP or local screening unit. The NHS leaflet sent with your invitation is designed to help you decide.

Clinical sources

This content is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional for personal medical guidance.